In years past, concerns have been raised over whether a growing radiation oncology workforce would eventually outpace patient demands, but a new report brings positive news.

A team of experts has been researching a method known as photo acoustic chemical imaging, or PACI, to understand how it can offer added insight into the chemical makeup of a tumor.  

New data suggest that it may not be necessary for women older than 65 with hormone receptor-positive breast cancer to undergo radiotherapy after breast-conserving surgery and hormone therapy, as it does not impact death rates or metastasis risk.

A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.

In March of 2022, 177Lu-PSMA-617 was approved by the U.S. Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer in men with PSMA-avid disease who have previously undergone chemotherapy and a novel androgen receptor-directed therapy. 

Incoming AAPM President Ehsan Samei, PhD, FACR, chief imaging physicist for Duke University Health System, helped develop two specialized radiology phantom astronauts to measure how much radiation NASA astronauts will receive on future Artemis missions to the Moon and beyond.

Cancer patients who are offered free hospital-provided rideshare services are more likely to comply with radiation therapy recommendations. 

Washington University is using a novel low-count quantitative SPECT technique to measure the concentration of alpha particle radiopharmaceutical therapy activity in the tumor and in radio-sensitive organs.